Clinical guidelines on long-term pharmacotherapy for bipolar disorder in children and adolescents

Joanna H. Cox, Stefano Seri, Andrea E. Cavanna

Research output: Contribution to journalReview article

Abstract

Bipolar disorder is a severe affective disorder which can present in adolescence, or sometimes earlier, and often requires a pharmacotherapeutic approach. The phenomenology of bipolar disorder in children and adolescents appears to differ from that of adult patients, prompting the need for specific pharmacotherapy guidelines for long-term management in this patient population. Current treatment guidelines were mainly developed based on evidence from studies in adult patients, highlighting the requirement for further research into the pharmacotherapy of children and adolescents with bipolar disorder. This review compares and critically analyzes the available guidelines, discussing the recommended medication classes, their mechanisms of action, side effect profiles and evidence base
LanguageEnglish
Pages135-143
Number of pages9
JournalJournal of Clinical Sleep Medicine
Volume3
Issue number1
DOIs
Publication statusPublished - 21 Jan 2014

Fingerprint

Bipolar Disorder
Guidelines
Drug Therapy
Mood Disorders
Research
Population
Therapeutics

Bibliographical note

© 2014 by the authors; licensee MDPI, Basel, Switzerland.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords

  • adolescents
  • bipolar disorder
  • children
  • guidelines
  • pharmacotherapy

Cite this

@article{1c0dc9dd52294526805634236c501808,
title = "Clinical guidelines on long-term pharmacotherapy for bipolar disorder in children and adolescents",
abstract = "Bipolar disorder is a severe affective disorder which can present in adolescence, or sometimes earlier, and often requires a pharmacotherapeutic approach. The phenomenology of bipolar disorder in children and adolescents appears to differ from that of adult patients, prompting the need for specific pharmacotherapy guidelines for long-term management in this patient population. Current treatment guidelines were mainly developed based on evidence from studies in adult patients, highlighting the requirement for further research into the pharmacotherapy of children and adolescents with bipolar disorder. This review compares and critically analyzes the available guidelines, discussing the recommended medication classes, their mechanisms of action, side effect profiles and evidence base",
keywords = "adolescents, bipolar disorder , children, guidelines, pharmacotherapy",
author = "Cox, {Joanna H.} and Stefano Seri and Cavanna, {Andrea E.}",
note = "{\circledC} 2014 by the authors; licensee MDPI, Basel, Switzerland. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",
year = "2014",
month = "1",
day = "21",
doi = "10.3390/jcm3010135",
language = "English",
volume = "3",
pages = "135--143",
number = "1",

}

Clinical guidelines on long-term pharmacotherapy for bipolar disorder in children and adolescents. / Cox, Joanna H.; Seri, Stefano; Cavanna, Andrea E.

Vol. 3, No. 1, 21.01.2014, p. 135-143.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Clinical guidelines on long-term pharmacotherapy for bipolar disorder in children and adolescents

AU - Cox, Joanna H.

AU - Seri, Stefano

AU - Cavanna, Andrea E.

N1 - © 2014 by the authors; licensee MDPI, Basel, Switzerland. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2014/1/21

Y1 - 2014/1/21

N2 - Bipolar disorder is a severe affective disorder which can present in adolescence, or sometimes earlier, and often requires a pharmacotherapeutic approach. The phenomenology of bipolar disorder in children and adolescents appears to differ from that of adult patients, prompting the need for specific pharmacotherapy guidelines for long-term management in this patient population. Current treatment guidelines were mainly developed based on evidence from studies in adult patients, highlighting the requirement for further research into the pharmacotherapy of children and adolescents with bipolar disorder. This review compares and critically analyzes the available guidelines, discussing the recommended medication classes, their mechanisms of action, side effect profiles and evidence base

AB - Bipolar disorder is a severe affective disorder which can present in adolescence, or sometimes earlier, and often requires a pharmacotherapeutic approach. The phenomenology of bipolar disorder in children and adolescents appears to differ from that of adult patients, prompting the need for specific pharmacotherapy guidelines for long-term management in this patient population. Current treatment guidelines were mainly developed based on evidence from studies in adult patients, highlighting the requirement for further research into the pharmacotherapy of children and adolescents with bipolar disorder. This review compares and critically analyzes the available guidelines, discussing the recommended medication classes, their mechanisms of action, side effect profiles and evidence base

KW - adolescents

KW - bipolar disorder

KW - children

KW - guidelines

KW - pharmacotherapy

U2 - 10.3390/jcm3010135

DO - 10.3390/jcm3010135

M3 - Review article

VL - 3

SP - 135

EP - 143

IS - 1

ER -